Please find below a list of trials that are currently accruing:
- A Phase I Study of BAY 2402234 in Patients with Advanced Myeloid Cancers
- A Phase I Study of AMG 427 in People with Recurrent or Persistent Acute Myeloid Leukemia
- A Phase I/II Study of SNDX-5613 in People with Recurrent or Persistent Acute Leukemia
- A Phase I Study of BTX-A51 in People with Recurrent or Persistent Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
- A Phase IB/II Study of KRT-232 and Cytarabine or Decitabine in People with Acute Myeloid Leukemia
- A Phase I Study of APR-246 with Venetoclax and Azacitidine in People with Persistent Acute Myeloid Leukemia
If you would like to contact us or refer a patient, please call 646-608-3749.